News

News

TSO3 Simplifies US Regulatory Approach for Faster Clearance – Regulatory Agency Acknowledges and Requests Cleaned Up Filing

Quebec City, December 14, 2012 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Corporation”) an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is simplifying its approach for US regulatory clearance of the STERIZONE® 125L+ Sterilizer, with a single cycle which offers improved claims. The Agency acknowledges the TSO3 approach and requests a cleaned-up and simplified filing for consistency throughout the entire document filed in April 2012.

Read more

News

TSO3 to hold Q3 2012 Financial Results Conference Call

Québec City, October 29, 2012 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Corporation”) an innovator in sterilization technology for medical devices in healthcare settings, will report Financial Results for the Third Quarter 2012 ended September 30, 2012 on Wednesday, November 7, 2012. TSO3 will host a Conference Call and a Webcast at 10:30 A.M. (ET) the same day to discuss financial results and update on recent activities.

Read more

News

TSO3 CEO to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston

Quebec City, August 13, 2012 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in low temperature sterilization technology for medical devices in healthcare settings, announced today that Mr. R.M. (Ric) Rumble, CEO of TSO3, will be giving a corporate presentation at 13:30 (ET) tomorrow, August 14 at the Canaccord Genuity 32nd Annual Growth Conference.

Read more

News

TSO3 AND GETINGE SIGN LETTER OF INTENT FOR GLOBAL DISTRIBUTION AGREEMENT

Quebec City, August 7, 2012 – TSO3 Inc. (“TSO3”) (TSX: TOS), an innovator in low temperature sterilization technology for medical devices in healthcare settings, is pleased to announce that it has signed today a Letter of Intent with Getinge Infection Control AB (GETINGE), a division of worldwide GETINGE GROUP headquartered in Sweden, for the purpose of completing a global channel partner agreement for its new generation STERIZONE® Sterilizers.

Read more